Food And Drug Administration
Following the approval from the US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/vial and 100 mg/vial (singe-dose vial), Natco Pharma will launch the drug on November 1, 2019 or earlier in the US market.
4.38 PM Jan 10th
will continue to supply of APIs across European Union that contributed about 37 percent of company`s revenue in FY16. Three days back, the same active pharmaceutical ingredient plant had received a warning letter from the US Food and Drug Administration. The USFDA had imposed import alert on the company
2.03 PM Jan 9th
Natco Pharma Ltd today said following the approval from US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/Vial and 100 mg/Vial (Singe-Dose Vial), it will launch the drug on November 1, 2019 or earlier in USA market.
2.22 PM Jan 6th
regulatory bodies in the world. During the year 2016, Indian companies secured highest number of approvals during last decade. Indian companies received approval for 201 Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (FDA) out of total 598 ANDA approvals. Thus
10.47 PM Jan 5th
Aurobindo Pharma has received US Food and Drug Administration`s (USFDA) approval for two of its generic drugs, following which the company stocks gained positive traction. Ziprasidone Hydrochloride, marketed by Pfizer, is used for the treatment of schizophrenia and acute mania. Indomethacin, which
2.23 PM Dec 30th 2016
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.